Northern Trust
JUNS

Northern Trust’s Jupiter Neurosciences JUNS Stock Holding History

Northern Trust’s Portfolio JUNS Stock Details JUNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.43K Hold
338
– – ﹤0.01% 4427
2026
Q1 		$9.54K Hold
338
– – ﹤0.01% 4375
2025
Q4 		$25.9K Buy
338
+7
+2% +$698 ﹤0.01% 4366
2025
Q3 		$43.7K Buy
+331
New +$37.7K ﹤0.01% 4298

Other funds holding JUNS

VC
Vestor Capital Chicago, Illinois $1.59B AUM 51.04% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.54B AUM 37.12% 1-Year Est. Return

Northern Trust's JUNS Position: Q2 2026 in Review

Northern Trust held its Jupiter Neurosciences (JUNS) position steady in Q2 2026 at 338 shares worth $5.43K. The position accounts for ﹤0.01% of the portfolio, ranked #4427.

Northern Trust first reported a position in JUNS in Q3 2025 and has held it in 4 quarters since. The position peaked at $43.7K in Q3 2025. 13 funds tracked by Wall St. Rank hold JUNS as of Q2 2026.

  • Northern Trust held 338 shares of Jupiter Neurosciences worth $5.43K as of Q2 2026.
  • Northern Trust left its Jupiter Neurosciences share count unchanged in Q2 2026.
  • Jupiter Neurosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4427 holding.
  • Northern Trust first reported a position in Jupiter Neurosciences in Q3 2025 and has held it in 4 quarters since.
  • Northern Trust's Jupiter Neurosciences position peaked at $43.7K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Jupiter Neurosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.